The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nolvadex D 20 mg Film-coated Tablets



AstraZeneca ABPA1019/014/001

Main Information

Trade NameNolvadex D 20 mg Film-coated Tablets
Active SubstancesTamoxifen
Dosage FormFilm-coated tablet
Licence HolderAstraZeneca AB
Licence NumberPA1019/014/001

Group Information

ATC CodeL02BA Anti-estrogens
L02BA01 tamoxifen

Status

License statusAuthorised
Licence Issued10/05/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back